Patent · US Active

Lanosterol prodrug compound and preparation method therefor and use thereof

US10738076B2 · kind B2 · utility

2Cited by

1References

13Claims

0Family size

Assignee

Zhongshan Ophthalmic Center, Sun Yat-sen University · CN

Inventors

Yizhi Liu · Tangxia, CN
Yandong WANG · Jiaocheng District, CN
Xiaolin Li · San Diego, US
Zhi Luo · Taichung, TW
Liang Shen · Shanghai, CN
Lijuan HOU · Shanghai, CN
Xinxin Wen · Shanghai, CN
Haiying He · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jan 25, 2018
Grant date	Aug 11, 2020
Priority date	—
Expiry date	Jan 25, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J51/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a lanosterol prodrug compound, a pharmaceutically acceptable salt and an isomer thereof, and a pharmaceutical composition comprising the lanosterol prodrug compound and the use thereof in the preparation of a drug for treating cataracts. The lanosterol prodrug compound has a better permeability than lanosterol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.